微生物检测市场报告：2030 年趋势、预测与竞争分析

微生物检测的趋势和预测

到 2030 年，全球微生物检测市场预计将达到 88 亿美元，2024 年至 2030 年复合年增长率为 8.7%。市场的主要驱动力是感染疾病负担的增加和传染病的爆发、微生物检测技术的持续进步以及政府和私人对感染疾病研究的资助不断增加。全球微生物检测市场前景广阔，呼吸系统疾病、血液感染疾病、胃肠道疾病、性行为感染、尿道感染感染和牙周疾病市场充满机会。

• Lucintel 预测，由于测试量的增加和技术的持续进步，测试设备在预测期内仍将占据更大的份额。
• 在这个市场中，由于 COVID-19 大流行以及识别和管理其他呼吸系统疾病的需求不断增加，预计呼吸系统疾病将出现最高增长。
• 由于先进的医疗设施和主要市场参与企业的存在，预计北美在预测期内将出现最高的成长。

微生物检测市场新趋势

微生物检测市场正在经历几个反映技术发展和不断变化的医疗需求的关键趋势。了解这些趋势对于市场相关人员至关重要。

• 自动化和人工智慧整合：微生物学测试中的自动化和人工智慧整合正在兴起，提高了测试效率、准确性和吞吐量。人工智慧演算法提高了资料分析和决策的复杂性，从而更快地得出结果并提高可靠性。
• 分子诊断：人们对 PCR 和 NGS 等分子诊断的兴趣与日俱增。两者对于病原体检测都具有敏感性和特异性。这些诊断方法变得越来越容易取得，对于早期、准确的疾病诊断至关重要。
• 就地检验：随着在尽可能短的时间内现场获得诊断结果的压力越来越大，对就地检验解决方案的需求从未如此强烈。 POC 测试提高了便利性并加速了临床和远端决策。
• 个人化医疗：个人化医疗的趋势正在透过个人化诊断和治疗决策对微生物检测产生影响。新的测试技术可以实现针对遗传和微生物特征的治疗策略。
• 强调感染疾病监测：加强感染疾病监测和监测有助于微生物检测创新的激增。目前，测试开发工作的重点是那些能够早期检测和监测新出现的病原体和抗菌素抗药性的测试。

因此，这种动态正在突破诊断、患者照护和整体紧迫健康问题的微生物检测领域的界限。

微生物检测市场的最新趋势

微生物检测市场的最新趋势表明技术进步和行业实践取得了重大飞跃。主要进展包括：

• 采用先进的诊断技术新的诊断平台和技术，例如多重检测和改进的PCR系统，正在减少分析时间并提高微生物检测的准确性。
• 自动化和机器人技术：实验室的自动化和机器人化简化了工作流程，减少了人为错误，并提高了吞吐量。
• 监管更新：更新的法律规范和标准将确保各种临床应用的可靠性和有效性，并为先进微生物测试的开发和检验提供动力。
• 增加研发投资：微生物检测技术的关键因素之一是对研发的大量投资，引进了更先进、更精确的诊断工具。
• 检测服务的全球扩张：微生物检测服务向新兴市场的扩张正在促进诊断的获取，并为全球卫生工作做出贡献，特别是在疾病高发地区。

这些因素进一步提高了微生物检测的能力，并提高了其在不同地区和应用中的有效性和可及性。

微生物检测市场的策略性成长机会

微生物检测市场为关键应用提供了几个策略性成长机会。识别和利用这些机会将促进市场的进一步成长。

• 医疗诊断：医疗机构中增加微生物检测将进一步改善疾病诊断和管理，特别是透过改进的技术提供更好、更快的诊断。
• 食品安全检验：食品安全检验领域不断增长的需求正在创造新的机会。此类测试将彻底改变这一领域，因为微生物测试的先进水平决定了食品的品质和安全性。
• 环境监测：环境监测被认为越来越需要微生物检测来检测水、空气和土壤中的污染物和病原体。该领域在环境健康领域的成长方面具有巨大的潜力。
• 製药业：製药业正在评估新的微生物测试在药物开发和品管中的应用。药品製造领域提供的创新测试解决方案存在成长机会。
• 动物诊断：兽医学中越来越多地采用微生物检测，为检测动物疾病和提供更好的治疗提供了更多机会，推动了这个不断增长的市场领域。

这些成长机会以及不断增加的应用正在影响微生物检测市场并推动整个产业的创新。

微生物检测市场推广因素及挑战

这些是影响市场的一些技术、经济和监管因素。了解微生物检测市场的驱动因素和挑战将有助于了解市场前景。

推动微生物检测市场的因素如下：

1. 技术进步： 1. 技术进步：PCR 和分子检测等诊断技术的进步将透过提高检测的准确性和效率来推动市场。

2. 不断增长的医疗需求：不断增长的医疗需求和对感染疾病的认识正在推动对先进微生物检测解决方案的需求，并有助于市场扩张。

3. 监管支援：支持性法律规范和标准促进新微生物检测技术的开发和实施，并确保其可靠性和有效性。

4. 增加研发投资：研发方面的大量投资正在推动微生物检测的创新，并导致先进诊断工具和技术的引入。

5. 全球卫生倡议：全球控制感染疾病和改善公共卫生的努力正在为扩大微生物检测创造机会，特别是在资源匮乏的新兴市场。

微生物检测市场面临的挑战如下。

1. 成本高：先进的微生物检测技术的采购成本可能非常昂贵。对于许多资源有限的环境和发展中地区来说，成本可能过高。

2. 监理挑战：法规环境严峻，但复杂的核准系统会减缓新技术引进测试市场的速度。

3. 整合到现有系统和工作流程中：许多新兴的微生物检测技术需要与现有系统和工作流程进行复杂的集成，有时需要进行重大调整。

这些市场驱动因素和挑战正在推动微生物检测市场的成长轨迹、技术进步和其他整体市场动态。

按细分领域进行微生物检测

该研究包括按产品类型、测试应用、最终用途和地区对全球微生物测试的预测。

国家微生物检测市场前景

由于新技术、对准确诊断测试的需求不断增加以及监管变化，全球微生物测试市场正在经历显着增长。以下是美国、中国、德国、印度和日本主要市场近期发展的摘要。

• 美国：美国市场对先进微生物检测技术（包括 PCR 和次世代定序）的需求不断增加。对快速诊断解决方案和个人化医疗的关注正在推动测试准确性和速度领域的创新，确保更好的患者治疗结果。
• 中国：中国微生物检测市场正在快速成长。推动这一市场的其他因素包括政府增加对医疗基础设施和研究的投资、采用先进的诊断技术以及加强感染疾病控制措施。
• 德国：德国继续走在微生物检测最新创新的前沿，将自动化和人工智慧融入检测过程中。新的法律规范已经到位，以支援临床和研究领域先进测试技术的开发和实施。
• 印度：由于人们对感染疾病的认识不断提高以及医疗服务的改善，印度的微生物检测市场正在扩大。此外，经济实惠的高通量诊断技术提高了可近性，并实现了更有效的疾病检测和监测。
• 日本：对分子诊断和生物资讯学的大量投资正在进一步发展日本微生物检测市场。面对人口老化和新感染风险等挑战，重点是提高检测的准确性和速度。

常问问题

Q1.市场规模有多大？

答：到 2030 年，全球微生物检测市场预计将达到 88 亿美元。

Q2.市场成长预测如何？

答：2024 年至 2030 年，全球微生物检测市场预计将以 8.7% 的复合年增长率成长。

Q3.影响市场成长的关键驱动因素是什么？

答：该市场的主要驱动力是感染疾病负担和传染病爆发的增加、微生物检测技术的持续进步以及政府和私人对感染疾病研究的资助不断增加。

Q4.市场的主要细分市场是什么？

答：微生物检测市场前景广阔，呼吸系统疾病、血液感染疾病、肠胃疾病、性行为感染、尿道感染、牙周疾病市场都有机会。

Q5.市场上主要企业有哪些？

答：微生物检测的主要企业如下。

• Bio-Rad Laboratories
• Abbott Laboratories
• Becton and Dickinson
• F. Hoffmann-La Roche
• Bruker Corporation
• Hologic Corporation
• Danaher Corporation
• Biomerieux
• Thermo Fisher Scientific
• Agilent Technologies

Q6.未来最大的细分市场是什么？

答：Lucintel 预测，由于测试量的增加和技术的持续进步，测试设备在预测期内仍将占据更大的份额。

Q7. 未来五年预计哪个地区的市场最大？

答：由于先进的医疗设施和主要市场参与企业的存在，预计北美在预测期内将出现最高的成长。

Q8. 可以客製化报告吗？

答：是的，Lucintel 列出了 10% 的客製化服务，无需额外费用。

目录

第一章执行摘要

第二章全球微生物检测市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球微生物检测市场趋势（2018-2023）与预测（2024-2030）
• 按产品分類的全球微生物检测市场
  • 装置
  • 试剂
• 按测试类型分類的全球微生物测试市场
  • 细菌
  • 病毒
  • 真菌
• 按应用分類的全球微生物检测市场
  • 呼吸系统疾病
  • 血流感染疾病
  • 消化系统疾病
  • 性行为感染传染病
  • 尿道感染
  • 牙周病
  • 其他的
• 按最终用途分類的全球微生物检测市场
  • 医院
  • 诊断中心
  • 学术研究所
  • 其他的

第四章 2018-2030年区域市场趋势及预测分析

• 全球微生物检测市场（按地区）
• 北美微生物检测市场
• 欧洲微生物检测市场
• 亚太微生物检测市场
• 其他地区微生物检测市场

第五章 竞争分析

• 产品系列分析
• 业务整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 按产品分類的全球微生物检测市场成长机会
  • 按测试类型分類的全球微生物测试市场成长机会
  • 全球微生物检测市场成长机会（按应用）
  • 按最终用途分類的全球微生物检测市场成长机会
  • 全球微生物检测市场按地区成长机会
• 全球微生物检测市场的新兴趋势
• 战略分析
  • 新产品开发
  • 扩大全球微生物检测市场的能力
  • 全球微生物检测市场的合併、收购与合资
  • 认证和许可

第七章主要企业概况

• Bio-Rad Laboratories
• Abbott Laboratories
• Becton and Dickinson
• F. Hoffmann-La Roche
• Bruker Corporation
• Hologic Corporation
• Danaher Corporation
• Biomerieux
• Thermo Fisher Scientific
• Agilent Technologies

Microbiology Testing Trends and Forecast

The future of the global microbiology testing market looks promising with opportunities in the respiratory diseases, bloodstream infection, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, and periodontal diseases markets. The global microbiology testing market is expected to reach an estimated $8.8 billion by 2030 with a CAGR of 8.7% from 2024 to 2030. The major drivers for this market are increasing burden of infectious diseases and outbreak of epidemics, on-going technological advancements in microbiology testing, and growing government as well as private-public funding for research on infectious diseases.

• Lucintel forecasts that instruments will remain the larger segment over the forecast period due to increasing testing volume and on-going technological advancements.
• Within this market, respiratory diseases is expected to witness the highest growth due to the covid-19 pandemic and growing requirement to identify and manage other respiratory ailments.
• North America is expected to witness highest growth over the forecast period due to presence of advanced healthcare facilities and existence of key market players in the region.

Emerging Trends in the Microbiology Testing Market

The Microbiology Testing market is evolving through several key trends that reflect both the development of technology and changes in healthcare needs. Understanding such trends is indispensable for the stakeholders of the market.

• Automation and AI Integration: Automation and the integration of artificial intelligence into microbiology testing have been on the rise, thus enhancing the efficiency, accuracy, and throughput of testing. AI algorithms enhance the sophistication of data analysis and decision-making, accelerating results and improving reliability.
• Molecular Diagnosis: There is an increasing interest in molecular diagnosis; these include PCR and NGS. Both are highly sensitive and specific against the detection of pathogens. These diagnostics are becoming increasingly accessible and crucial for early, accurate disease diagnosis
• Point-of-Care Testing: There has never been a greater need for point-of-care testing solutions with the increasing pressure to have diagnostic results on-site in as little time as possible. POC testing increases convenience and accelerates decision-making clinically and remotely.
• Personalized Medicine: One trend, personalized medicine, is having its impact felt on microbiology testing by moving diagnostics and therapeutic decisions onto an individualized basis. New testing technologies make therapeutic strategies targeted at the genetic and microbiological profile possible.
• More Emphasis on Infectious Diseases Surveillance: Increased infectious disease surveillance and monitoring have, therefore, contributed to an upsurge of innovation in microbiology testing. Efforts on test development now focus on those which will enable early detection and monitoring of emergent pathogens and resistance to antimicrobials.

These dynamics, therefore, are pushing the boundaries in the field of Microbiology Testing for diagnostics, patient care, and overall pressing health concerns.

Recent Developments in the Microbiology Testing Market

Recent trends in the Microbiology Testing market indicate giant strides in technological advancement and also industry practices. Key developments include:

• Wider use of advanced diagnostic technologies: Novel diagnostic platforms and technologies, such as multiplex assays, and improved PCR systems are reducing analysis time and enhancing the accuracy of microbiology testing, thereby aiding the better management of diseases.
• Automation and Robotics: Automation and robotics in test laboratories have smoothed the workflow, reduced human error, and increased throughputs, which are very important to deal with the high volume of tests efficiently.
• Regulatory Updates: An updated regulatory framework and standards will further provide a boost to developing and validating advanced microbiology tests by assuring their reliability and effectiveness in various clinical applications.
• Increased Investment in R&D: Among the major factors contributing to microbiology testing technologies are heavy investments in research and development, which introduced more sophisticated and precise diagnostic tools.
• Global Expansion of Testing Services: Expansion in microbiology testing services into emerging markets has been facilitating access to diagnostics, thereby helping global health initiatives, especially in areas with high disease prevalence.

These factors are further developing the capabilities of microbiology testing and enhancing the effectiveness and accessibility of the tests for various regions and applications.

Strategic Growth Opportunities for Microbiology Testing Market

There are a few strategic growth opportunities that the Microbiology Testing market presents for key applications. Identification and capitalization on such opportunities will facilitate further growth of the market.

• Medical Healthcare Diagnostics: Increased microbiology testing in health facilities will further improve the diagnosis and management of diseases, particularly with improved technologies to provide better and quicker diagnoses.
• Food Safety Testing: New opportunities are emerging with growing demands in the food safety testing segment. Advanced-level microbiology testing is what determines the quality and safety of the food products; therefore, such tests innovate in this field.
• Environmental Monitoring: Environmental monitoring is considered to show an increased need for microbiology tests to detect contaminants and pathogens in water, air, and soil. This area has immense potential in terms of growth in the field of environmental health.
• Pharmaceutical Industry: New microbiology tests are being evaluated by the pharmaceutical industry for applications in drug development and quality control. Innovative testing solutions provided in drug manufacturing have opportunities for growth.
• Veterinary Diagnostics: With the increased adoption of microbiology tests in veterinary medicine, more opportunities to detect diseases and provide better treatments for animals will arise, offering a boost in this growing market segment.

These growth opportunities are influencing the Microbiology Testing market with increasing applications and driving innovation across industries.

Microbiology Testing Market Driver and Challenges

These are some of the technological, economic, and regulatory factors affecting the market. Knowing the drivers and challenges of the Microbiology Testing market helps in understanding the market landscape.

The factors responsible for driving the microbiology testing market include:

1. Advancement of Technology: Diagnosis technologies such as PCR and molecular assays advance, thereby driving the market by increasing test accuracy and efficiency; hence, improving treatment due to better management of diseases and bringing better outcomes for patients.

2. Rising Healthcare Demand: Increasing healthcare needs and awareness of infectious diseases are fueling demand for advanced microbiology testing solutions, contributing to market expansion.

3. Regulatory Support: Supportive regulatory frameworks and standards are facilitating the development and implementation of new microbiology testing technologies, ensuring their reliability and effectiveness.

4. Increased R&D Investment: Significant investments in research and development are driving innovation in microbiology testing, leading to the introduction of advanced diagnostic tools and techniques.

5. Global Health Initiatives: Global efforts toward fighting infectious diseases and improving public health create opportunities for microbiology testing to expand, particularly in resource-poor and emerging markets.

Challenges in the microbiology testing market are:

1. High Costs: Advanced technologies for microbiology testing may be extremely expensive to procure. The cost could be beyond the means of many resource-constrained settings or developing regions.

2. Regulatory Challenges: Although the regulatory environment has been difficult, complex approval systems may delay the introduction of new technologies to the test market.

3. Integration into Existing Systems and Workflows: Most of the emerging microbiology testing technologies will require intricate integrations with existing systems and workflows, sometimes requiring considerable adjustments; hence, it may impact the speed with which they are adopted.

These drivers and challenges drive the Marketplace for Microbiology Testing with regard to growth trajectories, technological advances, and other overall market dynamics.

List of Microbiology Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies microbiology testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the microbiology testing companies profiled in this report include-

• Bio-Rad Laboratories
• Abbott Laboratories
• Becton and Dickinson
• F. Hoffmann-La Roche
• Bruker Corporation
• Hologic Corporation
• Danaher Corporation
• Biomerieux
• Thermo Fisher Scientific
• Agilent Technologies

Microbiology Testing by Segment

The study includes a forecast for the global microbiology testing by product, test type, application, end use, and region.

Microbiology Testing Market by Product [Analysis by Value from 2018 to 2030]:

• Instruments
• Reagents

Microbiology Testing Market by Test Type [Analysis by Value from 2018 to 2030]:

• Bacterial
• Viral
• Fungal

Microbiology Testing Market by Application [Analysis by Value from 2018 to 2030]:

• Respiratory Diseases
• Bloodstream Infection
• Gastrointestinal Diseases
• Sexually Transmitted Diseases
• Urinary Tract Infections
• Periodontal Diseases

Microbiology Testing Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostic Centers
• Academic & Research Institutes
• Others

Microbiology Testing Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Microbiology Testing Market

The market for Microbiology Testing has seen considerable growth worldwide due to emerging technologies, a growing need for accurate diagnostic testing, and changing regulations. The following provides a synopsis of some of the recent developments in the main markets, which are the United States, China, Germany, India, and Japan.

• United States: The USA market is observing a high demand for sophisticated microbiology testing technologies comprising PCR and next-generation sequencing. The focus on rapid diagnostic solutions and personalized medicine encourages innovation in the areas of test accuracy and speed, hence assuring better patient outcomes.
• China: China's microbiology testing market has grown rapidly. Other driving factors for this market are increased government investments in healthcare infrastructure and research, adoption of advanced diagnostic technologies, and enhanced focus on infectious disease control.
• Germany: Germany has continuously remained at the forefront of the latest innovations in microbiology testing, integrating automation and AI into test processes. New regulatory frameworks are being set up to support the development and implementation of advanced technologies for testing across both clinical and research settings.
• India: Growing awareness of infectious diseases, along with an increase in healthcare services in India, has enhanced the country's microbiology testing market. In addition, affordable, high-throughput diagnostic technologies have increased accessibility and allowed for greater efficiency in the detection and monitoring of diseases.
• Japan: With major investments in molecular diagnostics and bioinformatics, Japan's microbiology testing market is being further advanced. There is a focus on increasing the precision and speed of testing amid challenges involving an aging population and new infectious risks.

Features of the Global Microbiology Testing Market

Market Size Estimates: Microbiology testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Microbiology testing market size by various segments, such as by product, test type, application, end use, and region in terms of value ($B).

Regional Analysis: Microbiology testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, test types, applications, end uses, and regions for the microbiology testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the microbiology testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the microbiology testing market size?

Answer: The global microbiology testing market is expected to reach an estimated $8.8 billion by 2030.

Q2. What is the growth forecast for microbiology testing market?

Answer: The global microbiology testing market is expected to grow with a CAGR of 8.7% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the microbiology testing market?

Answer: The major drivers for this market are increasing burden of infectious diseases and outbreak of epidemics, on-going technological advancements in microbiology testing, and growing government as well as private-public funding for research on infectious diseases.

Q4. What are the major segments for microbiology testing market?

Answer: The future of the microbiology testing market looks promising with opportunities in the respiratory diseases, bloodstream infection, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, and periodontal diseases markets.

Q5. Who are the key microbiology testing market companies?

Answer: Some of the key microbiology testing companies are as follows:

• Bio-Rad Laboratories
• Abbott Laboratories
• Becton and Dickinson
• F. Hoffmann-La Roche
• Bruker Corporation
• Hologic Corporation
• Danaher Corporation
• Biomerieux
• Thermo Fisher Scientific
• Agilent Technologies

Q6. Which microbiology testing market segment will be the largest in future?

Answer: Lucintel forecasts that instruments will remain the larger segment over the forecast period due to increasing testing volume and on-going technological advancements.

Q7. In microbiology testing market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to presence of advanced healthcare facilities and existence of key market players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the microbiology testing market by product (instruments and reagents), test type (bacterial, viral, and fungal), application (respiratory diseases, bloodstream infection, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, periodontal diseases, and others), end use (hospitals, diagnostic centers, academic & research institutes, and others ), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Microbiology Testing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Microbiology Testing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Microbiology Testing Market by Product
  • 3.3.1: Instruments
  • 3.3.2: Reagents
• 3.4: Global Microbiology Testing Market by Test Type
  • 3.4.1: Bacterial
  • 3.4.2: Viral
  • 3.4.3: Fungal
• 3.5: Global Microbiology Testing Market by Application
  • 3.5.1: Respiratory Diseases
  • 3.5.2: Bloodstream Infection
  • 3.5.3: Gastrointestinal Diseases
  • 3.5.4: Sexually Transmitted Diseases
  • 3.5.5: Urinary Tract Infections
  • 3.5.6: Periodontal Diseases
  • 3.5.7: Others
• 3.6: Global Microbiology Testing Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Diagnostic Centers
  • 3.6.3: Academic & Research Institutes
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Microbiology Testing Market by Region
• 4.2: North American Microbiology Testing Market
  • 4.2.1: North American Microbiology Testing Market by Product: Instruments and Reagents
  • 4.2.2: North American Microbiology Testing Market by Application: Respiratory Diseases, Bloodstream Infection, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Others
• 4.3: European Microbiology Testing Market
  • 4.3.1: European Microbiology Testing Market by Product: Instruments and Reagents
  • 4.3.2: European Microbiology Testing Market by Application: Respiratory Diseases, Bloodstream Infection, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Others
• 4.4: APAC Microbiology Testing Market
  • 4.4.1: APAC Microbiology Testing Market by Product: Instruments and Reagents
  • 4.4.2: APAC Microbiology Testing Market by Application: Respiratory Diseases, Bloodstream Infection, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Others
• 4.5: ROW Microbiology Testing Market
  • 4.5.1: ROW Microbiology Testing Market by Product: Instruments and Reagents
  • 4.5.2: ROW Microbiology Testing Market by Application: Respiratory Diseases, Bloodstream Infection, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Microbiology Testing Market by Product
  • 6.1.2: Growth Opportunities for the Global Microbiology Testing Market by Test Type
  • 6.1.3: Growth Opportunities for the Global Microbiology Testing Market by Application
  • 6.1.4: Growth Opportunities for the Global Microbiology Testing Market by End Use
  • 6.1.5: Growth Opportunities for the Global Microbiology Testing Market by Region
• 6.2: Emerging Trends in the Global Microbiology Testing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Microbiology Testing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Microbiology Testing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bio-Rad Laboratories
• 7.2: Abbott Laboratories
• 7.3: Becton and Dickinson
• 7.4: F. Hoffmann-La Roche
• 7.5: Bruker Corporation
• 7.6: Hologic Corporation
• 7.7: Danaher Corporation
• 7.8: Biomerieux
• 7.9: Thermo Fisher Scientific
• 7.10: Agilent Technologies